Effect of Two Different Weight-Loss Rates on Body Composition and Strength and Power-Related Performance in Elite Athletes

2011 ◽  
Vol 21 (2) ◽  
pp. 97-104 ◽  
Author(s):  
Ina Garthe ◽  
Truls Raastad ◽  
Per Egil Refsnes ◽  
Anu Koivisto ◽  
Jorunn Sundgot-Borgen
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Body Weight ◽  
Elite Athletes ◽  
Countermovement Jump ◽  
Repetition Maximum ◽  
Before And After ◽  
The Mean ◽  
And Performance ◽  
Better Than

When weight loss (WL) is necessary, athletes are advised to accomplish it gradually, at a rate of 0.5–1 kg/wk. However, it is possible that losing 0.5 kg/wk is better than 1 kg/wk in terms of preserving lean body mass (LBM) and performance. The aim of this study was to compare changes in body composition, strength, and power during a weekly body-weight (BW) loss of 0.7% slow reduction (SR) vs. 1.4% fast reduction (FR). We hypothesized that the faster WL regimen would result in more detrimental effects on both LBM and strength-related performance. Twenty-four athletes were randomized to SR (n = 13, 24 ± 3 yr, 71.9 ± 12.7 kg) or FR (n = 11, 22 ± 5 yr, 74.8 ± 11.7 kg). They followed energy-restricted diets promoting the predetermined weekly WL. All athletes included 4 resistance-training sessions/wk in their usual training regimen. The mean times spent in intervention for SR and FR were 8.5 ± 2.2 and 5.3 ± 0.9 wk, respectively (p < .001). BW, body composition (DEXA), 1-repetition-maximum (1RM) tests, 40-m sprint, and countermovement jump were measured before and after intervention. Energy intake was reduced by 19% ± 2% and 30% ± 4% in SR and FR, respectively (p = .003). BW and fat mass decreased in both SR and FR by 5.6% ± 0.8% and 5.5% ± 0.7% (0.7% ± 0.8% vs. 1.0% ± 0.4%/wk) and 31% ± 3% and 21 ± 4%, respectively. LBM increased in SR by 2.1% ± 0.4% (p < .001), whereas it was unchanged in FR (–0.2% ± 0.7%), with significant differences between groups (p < .01). In conclusion, data from this study suggest that athletes who want to gain LBM and increase 1RM strength during a WL period combined with strength training should aim for a weekly BW loss of 0.7%.

Long-Term Effect of Weight Loss on Body Composition and Performance in Elite Athletes

2011 ◽  
Vol 21 (5) ◽  
pp. 426-435 ◽  
Author(s):  
Ina Garthe ◽  
Truls Raastad ◽  
Jorunn Sundgot-Borgen
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Body Mass ◽  
Elite Athletes ◽  
Energy Restriction ◽  
Upper Body ◽  
Body Strength ◽  
Upper Body Strength ◽  
And Performance

Context:When weight loss (WL) is needed, it is recommended that athletes do it gradually by 0.5–1 kg/wk through moderate energy restriction. However, the effect of WL rate on long-term changes in body composition (BC) and performance has not been investigated in elite athletes.Purpose:To compare changes in body mass (BM), fat mass (FM), lean body mass (LBM), and performance 6 and 12 mo after 2 different WL interventions promoting loss of 0.7% vs. 1.4% of body weight per wk in elite athletes.Methods:Twenty-three athletes completed 6- and 12-mo postintervention testing (slow rate [SR] n = 14, 23.5 ± 3.3 yr, 72.2 ± 12.2 kg; fast rate [FR] n = 9, 21.4 ± 4.0 yr, 71.6 ± 12.0 kg). The athletes had individualized diet plans promoting the predetermined weekly WL during intervention, and 4 strength-training sessions per wk were included. BM, BC, and strength (1-repetition maximum) were tested at baseline, postintervention, and 6 and 12 mo after the intervention.Results:BM decreased by ~6% in both groups during the intervention but was not different from baseline values after 12 mo. FM decreased in SR and FR during the intervention by 31% ± 3% vs. 23% ± 4%, respectively, but was not different from baseline after 12 mo. LBM and upper body strength increased more in SR than in FR (2.0% ± 1.3% vs. 0.8% ± 1.1% and 12% ± 2% vs. 6% ± 2%) during the intervention, but after 12 mo there were no significant differences between groups in BC or performance.Conclusion:There were no significant differences between groups after 12 mo, suggesting that WL rate is not the most important factor in maintaining BC and performance after WL in elite athletes.

Effects of COVID-19 Lockdown and a Subsequent Retraining Period on Elite Athletes’ Workload, Performance, and Autonomic Responses: A Case Series

2020 ◽  
pp. 1-5
Author(s):  
Pedro L. Valenzuela ◽  
Fernando Rivas ◽  
Guillermo Sánchez-Martínez
Keyword(s):  
Heart Rate ◽  
Heart Rate Variability ◽  
Elite Athletes ◽  
Case Series ◽  
Negative Consequences ◽  
Countermovement Jump ◽  
Repetition Maximum ◽  
Individual Level ◽  
Autonomic Responses ◽  
And Performance

Purpose: To describe the effects of COVID-19 lockdown and a subsequent retraining on the training workloads, autonomic responses, and performance of a group of elite athletes. Methods: The training workloads and heart rate variability (assessed through the log-transformed root mean square of successive R–R intervals) of 7 elite badminton players were registered daily during 4 weeks of normal training (baseline), 7 to 10 weeks of lockdown, and 6 to 8 weeks of retraining. Physical performance was assessed at baseline and after each phase by means of a countermovement jump and the estimated squat 1-repetition maximum. Results: A reduction in training workloads was observed in all participants during the lockdown (−63.7%), which was accompanied by a reduced heart rate variability in all but one participant (−2.0%). A significant reduction was also observed for countermovement jump (−6.5%) and 1-repetition maximum performance (−11.5%), which decreased in all but one participant after the lockdown. However, after the retraining phase, all measures returned to similar values to those found at baseline. At the individual level, there were divergent responses, as exemplified by one athlete who attenuated the reduction in training workloads and increased her performance during the lockdown and another one who markedly reduced his workload and performance, and got injured during the retraining phase. Conclusions: Although there seems to be a large interindividual variability, COVID-19 lockdown is likely to impose negative consequences on elite athletes, but these detrimental effects might be avoided by attenuating reductions in training workloads and seem to be overall recovered after 6 to 8 weeks of retraining.

A Pilot Study Comparing Megestrol Acetate Concentrated Suspension (MA-CS) to Megestrol Acetate Oral Suspension (MA-OS) on Weight Gain and Body Composition in Patients with HIV-Associated Unintended Weight Loss (UWL).

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1433-1433
Author(s):  
Donald D. Cilla ◽  
Jodi L. Gutierrez ◽  
Robert A. Femia ◽  
Lynn D. Kramer ◽  
Christine Wanke
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Body Weight ◽  
Lean Body Mass ◽  
Body Mass ◽  
Megestrol Acetate ◽  
Weight Changes ◽  
Treatment Groups ◽  
Fasted State ◽  
The Mean

Abstract BACKGROUND: MA-CS is a new NanoCrystal® technology formulation of megestrol acetate that is bioavailable in the fasted state, which may provide benefit in the treatment of UWL in HIV patients. METHODS: 63 patients with HIV-associated UWL (weight loss to 90% of the lower limit of ideal body weight) were recruited from South Africa, India and the US and then randomized to receive MA-CS (575 mg/5 mL) or MA-OS (800 mg/20 mL) once-daily for 12 weeks in a randomized, open-labeled, multi-center, pilot proof-of-principle study (sample size determined empirically). Patients had weight, body composition (bioimpedance analysis - BIA), and anthropometric measurements obtained at baseline and weekly thereafter, except BIA which was measured at 6 and 12 weeks. Weight changes were compared using the Wilcoxon Rank Sum test. RESULTS: The demographics were comparable between the two groups. The mean weight change from baseline to Week 12 for MA-CS was 5.4 kg (55.6 kg to 61 kg, 10% of baseline body weight). The mean weight change from baseline to Week 12 for MA-OS was 3.5 kg (54.4 kg to 57.9 kg, 6% of baseline body weight). Differences from baseline, in the mean changes in weight, were observed as early as Day 3 (p=0.024) for MA-CS, however no increase was noted until the second week for MA-OS. Similar between group differences were noted consistently at the weekly assessment intervals until week 12 (p= 0.024). Of these weight changes, lean body mass accounted for ~40% of the increase in both treatment groups (MA-CS was ~5% greater than MA-OS). Of the anthropometric measures, the mean triceps skin fold increased by ~36% at Week 12, relative to baseline, in both MA-CS and MA-OS treatment groups. Other anthropometric changes were all smaller (less than 7%) and comparable between treatments. The types and incidence rates of adverse events were similar between MA-CS and MA-OS. CONCLUSIONS: Both products were successful at increasing body weight. There was a greater and more rapid mean change from baseline in the weight gain for MA-CS than MA-OS. The observed weight changes reflected increases in both lean body mass and body fat. MA-CS had a greater change in lean body mass. This trial supports the principle that improved bioavailability of megestrol acetate in the fasted state with MA-CS may be associated with faster time to onset of changes in body weight.

scholarly journals Evaluation of Toyocerin®, a probiotic containing Bacillus toyoi spores, on the health status and performance of sows and their litters

2017 ◽  
Vol 55 (1) ◽  
pp. 34 ◽  
Author(s):  
I. E. GEORGOULAKIS (I.E. ΓΕΩΡΓΟΥΛΑΚΗΣ) ◽  
C. ALEXOPOULOS (Κ. ΑΛΕΞΟΠΟΥΛΟΣ) ◽  
Ch. MILIOTIS (Χ. ΜΗΛΙΩΤΗΣ) ◽  
E. E. MALANDRAKIS (Ε.Ε. ΜΑΛΑΝΔΡΑΚΗΣ) ◽  
S. C. KYRIAKIS (Σ.Κ. ΚΥΡΙΑΚΗΣ)
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Health Status ◽  
Clinical Signs ◽  
Beneficial Effects ◽  
Breeding Cycles ◽  
The Mean ◽  
And Performance ◽  
Positive Effect

The aim of this study was to assess the efficacy of Toyocerin®, a probiotic containing l x l09Bacillus toyoi spores per gram, on the health status and productivity of sows and their litters. Eighty gilts and sows were allocated into four experimental groups as follows: TOYO - 0 = control, TOYO - 0.5 = 0.5xl09 Bacillus toyoi spores/kg of feed, TOYO - 1 = l.0xl09Bacillus toyoi spores/kg of feed, TOYO - 2 = 2.0x109Bacillus toyoi spores/kg of feed. The treatments started at the day of service and covered two complete breeding cycles. Toyocerin® supplementation of the feed improved gilt/sow performance by: increasing (P<0.05) the mean body weight from service to farrowing, decreasing (P<0.05) the mean weight loss from farrowing to weaning and decreasing (P<0.05) the mean weaning-to-conception interval. Toyocerin® also showed a positive effect on litter characteristics in terms of: higher (P<0.05) mean number of piglets born alive at each birth, higher (P<0.05) mean number of piglets weaned, a higher (P<0.05) mean piglet body weight at each weaning and lower (P<0.05) mean diarrhoea score. Finally, Toyocerin® tended to improve the health status and fertility of sows demonstrating: a tendency for lower percentages of sows with abnormal clinical signs and a similar effect on the percentages of sows returning to oestrus. These beneficial effects of Toyocerin® were more pronounced in the TOYO - 1 and the TOYO – 2 groups.

scholarly journals Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention

2016 ◽  
Vol 41 (3) ◽  
pp. 307-314 ◽  
Author(s):  
Barbara Szendrei ◽  
Domingo González-Lamuño ◽  
Teresa Amigo ◽  
Guan Wang ◽  
Yannis Pitsiladis ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Body Weight ◽  
Fat Mass ◽  
Current Evidence ◽  
Fat Percentage ◽  
Endurance Strength ◽  
Diet And Exercise ◽  
Before And After ◽  
Physical Activity Recommendations

The β-2 and β-3 adrenergic receptors (ADRB2 and ADRB3) are thought to play a role in energy expenditure and lipolysis. However, the effects of the ADRB2 glutamine (Gln) 27 glutamic acid (glutamate) (Glu) and ADRB3 tryptophan (Trp) 64 arginine (Arg) polymorphisms on weight loss remain controversial. The aim of this study was to investigate the effect of these polymorphisms on changes in weight and body composition during a controlled weight-loss program. One hundred seventy-three healthy overweight and obese participants (91 women, 82 men) aged 18–50 years participated in a 22-week-long intervention based on a hypocaloric diet and exercise. They were randomly assigned to 1 of 4 groups: strength, endurance, strength and endurance combined, and physical activity recommendations only. Body weight, body mass index (BMI), and body composition variables were assessed before and after the intervention. Genetic analysis was carried out according to standard protocols. No effect of the ADRB2 gene was shown on final weight, BMI, or body composition, although in the supervised male group, Glu27 carriers tended to have greater weight (p = 0.019, 2.5 kg) and BMI (p = 0.019, 0.88 kg/m2) reductions than did noncarriers. There seems to be an individual effect of the ADRB3 polymorphism on fat mass (p = 0.004) and fat percentage (p = 0.036), in addition to an interaction with exercise for fat mass (p = 0.038). After the intervention, carriers of the Arg64 allele had a greater fat mass and fat percentage than did noncarriers (p = 0.004, 2.8 kg). In conclusion, the ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms may influence weight loss and body composition, although the current evidence is weak; however, further studies are necessary to clarify their roles.

scholarly journals Isoquinoline Alkaloids in Sows’ Diet Reduces Body Weight Loss during Lactation and Increases IgG in Colostrum

Animals ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 2195
Author(s):  
Ester Arévalo Sureda ◽  
Xuemei Zhao ◽  
Valeria Artuso-Ponte ◽  
Sophie-Charlotte Wall ◽  
Bing Li ◽  
...  
Keyword(s):  
Gene Expression ◽  
Weight Loss ◽  
Body Weight ◽  
Body Weight Loss ◽  
Muscle Thickness ◽  
Passive Immunity ◽  
Isoquinoline Alkaloids ◽  
Back Muscle ◽  
Fat Thickness ◽  
And Performance

Isoquinoline alkaloids (IQ) exert beneficial antimicrobial and anti-inflammatory effects in livestock. Therefore, we hypothesized that supplementing sows’ diets with IQ during gestation would decrease farrowing stress, affecting the piglets’ development and performance. Sows were divided into: IQ1, supplemented with IQ from gestation day 80 (G80) to weaning; IQ2, supplemented from gestation day 110 (G110) to weaning, and a non-supplemented (NC) group. Sow body weight (BW), feed intake, back-fat thickness and back-muscle thickness were monitored. Cortisol, glucose and insulin were measured in sows’ blood collected 5 d before, during, and after 7 d farrowing. Protein, fat, IgA and IgG were analyzed in the colostrum and milk. Piglets were monitored for weight and diarrhea score, and for ileum histology and gene expression 5 d post-weaning. IQ-supplemented sows lost less BW during lactation. Glucose and insulin levels were lower in the IQ groups compared to NC-sows 5 d before farrowing and had higher levels of protein and IgG in their colostrum. No other differences were observed in sows, nor in the measured parameters in piglets. In conclusion, IQ supplementation affected sows’ metabolism, reducing body weight loss during lactation. Providing IQ to sows from their entrance into the maternity barn might be sufficient to induce these effects. IQ improved colostrum quality, increasing the protein and IgG content, improving passive immunity for piglets.

scholarly journals European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis

Obesity Facts ◽  
2021 ◽  
Vol 14 (2) ◽  
pp. 222-245
Author(s):  
Giovanna Muscogiuri ◽  
Marwan El Ghoch ◽  
Annamaria Colao ◽  
Maria Hassapidou ◽  
Volkan Yumuk ◽  
...  
Keyword(s):  
Systematic Review ◽  
Weight Loss ◽  
Body Composition ◽  
Body Weight ◽  
Side Effects ◽  
Ketogenic Diet ◽  
Meta Analysis ◽  
Dietary Treatment ◽  
Obesity Management ◽  
Weight Loss Interventions

<b><i>Background:</i></b> The very low-calorie ketogenic diet (VLCKD) has been recently proposed as an appealing nutritional strategy for obesity management. The VLCKD is characterized by a low carbohydrate content (&#x3c;50 g/day), 1–1.5 g of protein/kg of ideal body weight, 15–30 g of fat/day, and a daily intake of about 500–800 calories. <b><i>Objectives:</i></b> The aim of the current document is to suggest a common protocol for VLCKD and to summarize the existing literature on its efficacy in weight management and weight-related comorbidities, as well as the possible side effects. <b><i>Methods:</i></b> This document has been prepared in adherence with Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Literature searches, study selection, methodology development, and quality appraisal were performed independently by 2 authors and the data were collated by means of a meta-analysis and narrative synthesis. <b><i>Results:</i></b> Of the 645 articles retrieved, 15 studies met the inclusion criteria and were reviewed, revealing 4 main findings. First, the VLCKD was shown to result in a significant weight loss in the short, intermediate, and long terms and improvement in body composition parameters as well as glycemic and lipid profiles. Second, when compared with other weight loss interventions of the same duration, the VLCKD showed a major effect on reduction of body weight, fat mass, waist circumference, total cholesterol and triglyceridemia as well as improved insulin resistance. Third, although the VLCKD also resulted in a significant reduction of glycemia, HbA1c, and LDL cholesterol, these changes were similar to those obtained with other weight loss interventions. Finally, the VLCKD can be considered a safe nutritional approach under a health professional’s supervision since the most common side effects are usually clinically mild and easily to manage and recovery is often spontaneous. <b><i>Conclusions:</i></b> The VLCKD can be recommended as an effective dietary treatment for individuals with obesity after considering potential contra-indications and keeping in mind that any dietary treatment has to be personalized. <b><i>Prospero Registry:</i></b> The assessment of the efficacy of VLCKD on body weight, body composition, glycemic and lipid parameters in overweight and obese subjects: a meta-analysis (CRD42020205189).

scholarly journals Effect of Mixed Nuts on Body Weight and Composition, and Gut Microbiome (P08-054-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Shih Lung Woo ◽  
Dina Ben-Nissan ◽  
Zahra Ezzat-Zadeh ◽  
Jieping Yang ◽  
Lijun Zhang ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Body Weight ◽  
Gut Microbiome ◽  
Plasma Lipids ◽  
Plasma Lipid ◽  
Healthy Weight ◽  
Weight Changes ◽  
Fecal Microbiome ◽  
Tree Nuts

Abstract Objectives This study was designed to assess the effects of mixed nut consumption on body weight and composition, and gut microbiome in obese individuals. Primary outcome was change in body weight and composition. Secondary outcomes include gut microbiome composition, inflammatory markers, and plasma lipids. Methods The reported results are from an interim analysis (n = 50) of a randomized, placebo controlled, parallel study. Total enrollment target is 154 overweight/obese subjects (BMI 27–35 kg/m2). Participants were randomly assigned to consume either 1.5oz mixed tree nuts or pretzels with equal calorie content daily for 24 weeks. The study included a 12-week weight loss phase (500 kcal per day less than total daily energy expenditure), followed by a 12-week weight maintenance phase. Body composition, fasting blood, and stool samples were collected at baseline, week 12 and 24. Body composition, and vitals were analyzed, whereas plasma lipid profile, fecal microbiome, and microbiome metabolites analysis is still pending. Results At week 12, subjects from both the pretzel (n = 15, 10 dropouts; P = 0.009) and nut group (n = 22, 3 dropouts; P = 0.038) lost significant amount of weight. The trend of weight changes did not differ between groups (P = 0.530). Subjects from both groups were able to sustain weight loss through 24 weeks (pretzel: 81.43 ± 3.85 kg at baseline vs. 79.43 ± 4.08 kg at week 24, P = 0.028; nut: 84.26 ± 3.78 kg at baseline vs. 82.38 ± 3.72 kg at week 24, P = 0.026). At week 12, fat mass in both groups was significantly decreased (pretzel: P = 0.002; nut: P = 0.012). The trend of fat changes did not differ between groups (P = 0.547). Subjects from both groups were able to sustain fat loss through 24 weeks (pretzel: 30.84 ± 1.75 kg at baseline vs. 29.25 ± 2.12 kg at week 24, P = 0.024; nut: 31.51 ± 1.56 kg vs 30.21 ± 1.81 kg at week 24, P = 0.04). Muscle mass, and blood pressure were not significantly different between both groups. Conclusions Our data suggested that tree nuts could be consumed as part of a healthy weight loss meal plan without concern of causing weight gain. Further analysis of the remaining samples is needed to confirm results. Due to higher dropouts in the pretzel group, future intention-to-treat analysis is also needed to eliminate bias. Funding Sources This study is supported by the International Tree Nut Council.

scholarly journals Uric acid is associated with adiposity factors, especially with fat mass reduction during weight loss in obese children and adolescents

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Yang Niu ◽  
Xue-lin Zhao ◽  
Hui-juan Ruan ◽  
Xiao-meng Mao ◽  
Qing-ya Tang
Keyword(s):  
Weight Loss ◽  
Body Composition ◽  
Uric Acid ◽  
Children And Adolescents ◽  
Body Fat ◽  
Fat Mass ◽  
Dietary Control ◽  
Obese Children ◽  
Fat Percentage ◽  
Before And After

Abstract Background Current adult studies suggest that uric acid (UA) is associated with body fat, but the relationship in obese children is unclear. Thus, we aim to evaluate the association between uric acid and body composition of obese children. Methods A total of 79 obese children were included in this study, and 52 children (34 boys and 18 girls) underwent a 6-week weight loss camp, including 34 boys and 18 girls. Six-week weight-loss interventions were performed on all participants through aerobic exercise and appropriate dietary control. Laboratory tests and body composition were collected before and after the intervention. Results Before the intervention, correlation analysis demonstrated that uric acid was positively correlated with height, weight, body mass index (BMI), waist circumference, hip circumference, fat mass (FM), and free fat mass (FFM) with adjusting for age and gender (P < 0.05). After 6 weeks of intervention, the participants gained 3.12 ± 0.85 cm in height, body fat percentage decreased by 7.23 ± 1.97%, and lost 10.30 ± 2.83 kg in weight. Univariate and multivariate analysis indicated that uric acid at baseline was associated with FM reduction during weight loss (P < 0.05). Conclusions This study is the first report that uric acid is associated with BMI and FM, and may play an important role in the reduction of FM during weight loss in obese children and adolescents. The interaction between UA and adiposity factors and its underlying mechanisms need to be further explored. Trial registration This study was registered in Clinical Trials.gov (NCT03490448) and approved by the Ethics Committee of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

Sign in / Sign up

Export Citation Format

Share Document